Potential Benefits of Novel Weight Loss Medication on Blood Pressure in Adults with Obesity

18 July 2024

A study highlighted in the journal Hypertension indicates promising benefits of tirzepatide, a novel weight loss medication, in reducing systolic blood pressure among obese adults.…

Continue reading →

Controlling Chronic Inflammation: Applying the Brakes

10 July 2024

Researchers at Weill Cornell Medicine have made a significant discovery linking two critical pathways that control the immune system in mammals. This discovery sheds new…

Continue reading →

Projected Population Shifts and Risk Factors Expected to Triple U.S. Cardiovascular Disease Costs by 2050

9 July 2024

Driven by an increasingly diverse and ageing population, coupled with a significant rise in risk factors such as hypertension and obesity, the projected costs associated…

Continue reading →

Patient-centered cardiovascular care is essential for enhancing equity and outcomes

3 May 2024

A new Scientific Statement from the American Heart Association, published in Circulation, emphasizes the significant benefits of adopting a patient-centred approach to adult cardiovascular care.…

Continue reading →